Evidence supporting this notion is consistent with clinical observations that α-cell insulin resistance exaggerates glucagon responses to stimuli in type 2 diabetic patients (Tsuchiyama et al., 2007). This evidence concerns the gene GCG and type 2 diabetes mellitus.